Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Aliskiren, a Novel Orally Effective Renin Inhibitor, Provides Dose-Dependent Antihypertensive Efficacy and Placebo-Like Tolerability in Hypertensive Patients
PaperCitations, authors & open-access status
Aliskiren, a Novel Orally Effective Renin Inhibitor, Provides Dose-Dependent Antihypertensive Efficacy and Placebo-Like Tolerability in Hypertensive Patients is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 524 citations, 2005 year and closed oa status.
524
Citations
2005
Year
closed
OA Status